Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 6.1T | 7.8T | 6.8T | 6.7T |
| Cost of revenue | 5.3T | 6.9T | 6.0T | 6.1T |
| Gross profit | 742.8B | 900.7B | 843.2B | 613.6B |
| Operating expense | ||||
| Research & development | 351.1B | 376.5B | 387.5B | 343.9B |
| Selling general and admin | 292.6B | 364.6B | 454.8B | 276.9B |
| Other operating expenses | — | — | — | — |
| Operating income | 33.5B | 83.1B | -80.6B | -93.7B |
| Non operating interest income | ||||
| Income | 22.0B | 18.7B | 24.5B | 23.2B |
| Expense | 201.0B | 219.7B | 233.5B | 238.1B |
| Other income expense | -1.3B | -438.6B | 90.6B | -116.6B |
| Pretax income | -148.5B | -562.4B | -207.2B | -432.6B |
| Tax provision | 88.5B | 276.8B | 130.9B | 38.2B |
| Net income | -237.0B | -839.1B | -338.1B | -470.8B |
| Basic EPS | -262.5 | — | -355 | -506.5 |
| Diluted EPS | -262.5 | — | -355 | -506.5 |
| Basic average shares | 1B | — | 1B | 1B |
| Diluted average shares | 1B | — | 1B | 1B |
| EBITDA | 1.2T | 1.3T | -7.2B | -10.8B |
| Net income from continuing op. | -237.0B | -839.1B | — | — |
| Minority interests | -25.7B | -78.6B | -17.1B | -35.7B |
| Preferred stock dividends | — | — | — | — |